3:44 PM
 | 
Jan 23, 2019
 |  BC Extra  |  Company News

Management tracks: Cabaletta, Sage, MyoKardia

Autoimmune cell therapy company Cabaletta Bio Inc. (Radnor, Pa.) hired Anup Marda as CFO. He was VP and head of global corporate financial planning and analysis at Bristol-Myers Squibb Co. (NYSE:BMY). Marda succeeds interim CFO Dan Geffken.

CNS disorders company Sage Therapeutics Inc. (NASDAQ:SAGE) appointed Elizabeth Barrett and George Golumbeski to its board. Barrett became president and CEO of UroGen Pharma Ltd. (NASDAQ:URGN) this month after departing Novartis AG...

Read the full 322 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >